Literature DB >> 7726526

Right-sided endocarditis caused by Staphylococcus aureus in drug abusers.

J Fortún1, J A Pérez-Molina, M T Añón, J Martínez-Beltrán, E Loza, A Guerrero.   

Abstract

A prospective, open, and randomized study of right-sided endocarditis caused by Staphylococcus aureus in drug abuse patients is reported. The following parenteral treatments were compared. Group A patients were treated with 2 g of cloxacillin every 4 h and 1.5 mg of gentamicin per kg of body weight every 8 h for 2 weeks. Group B patients were treated with teicoplanin at 10 mg/kg/12 h on the 1st to 3rd days, 6 mg/kg/12 h on the 4th to 7th days, and 7 mg/kg/24 h on the 8th days. Drug abusers with bacteremia caused by S. aureus and suggestive signs of endocarditis were included. Clinical failures were observed in one patient in group A and in four of six patients in group B. Three patients in group B developed breakthrough bacteremia with teicoplanin-susceptible strains on days +6, +14, and +19. Serum teicoplanin levels and serum bactericidal titers showed a decrease in the 2nd week, when dosages received were 7 mg/kg/day. In conclusion, in treatment of right-sided endocarditis caused by S. aureus in drug abusers with teicoplanin, the use of dosages of 7 mg/kg/day is not recommended even if patients have received dosages of 12 mg/kg/day during the 1st week.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7726526      PMCID: PMC162572          DOI: 10.1128/AAC.39.2.525

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

Review 1.  Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci.

Authors:  A L Bisno; W E Dismukes; D T Durack; E L Kaplan; A W Karchmer; D Kaye; S H Rahimtoola; M A Sande; J P Sanford; C Watanakunakorn
Journal:  JAMA       Date:  1989-03-10       Impact factor: 56.272

Review 2.  Microbiological properties of teicoplanin.

Authors:  D Greenwood
Journal:  J Antimicrob Chemother       Date:  1988-01       Impact factor: 5.790

3.  A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria.

Authors:  P Lewis; J J Garaud; F Parenti
Journal:  J Antimicrob Chemother       Date:  1988-01       Impact factor: 5.790

Review 4.  Dosage recommendations for teicoplanin.

Authors:  A P Wilson; R N Grüneberg; H Neu
Journal:  J Antimicrob Chemother       Date:  1993-12       Impact factor: 5.790

5.  Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.

Authors:  P Van der Auwera; P Joly
Journal:  J Antimicrob Chemother       Date:  1987-03       Impact factor: 5.790

Review 6.  Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy.

Authors:  A W Karchmer
Journal:  Am J Med       Date:  1985-06-28       Impact factor: 4.965

7.  Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.

Authors:  H F Chambers; R T Miller; M D Newman
Journal:  Ann Intern Med       Date:  1988-10-15       Impact factor: 25.391

8.  Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers.

Authors:  B Abrams; A Sklaver; T Hoffman; R Greenman
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

9.  Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections.

Authors:  M R Bibler; P T Frame; D N Hagler; R B Bode; J L Staneck; V Thamlikitkul; J E Harris; A Haregewoin; W E Bullock
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

10.  Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography.

Authors:  A C Cremieux; B Maziere; J M Vallois; M Ottaviani; A Azancot; H Raffoul; A Bouvet; J J Pocidalo; C Carbon
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

View more
  4 in total

1.  A comparison of different antibiotic regimens for the treatment of infective endocarditis.

Authors:  Arturo J Martí-Carvajal; Mark Dayer; Lucieni O Conterno; Alejandro G Gonzalez Garay; Cristina Elena Martí-Amarista
Journal:  Cochrane Database Syst Rev       Date:  2020-05-14

2.  Impact of rapid diagnosis of Staphylococcus aureus bacteremia from positive blood cultures on patient management.

Authors:  M P Romero-Gómez; E Cendejas-Bueno; J García Rodriguez; J Mingorance
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-23       Impact factor: 3.267

Review 3.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

4.  Infective Endocarditis in Intravenous Drug Abusers.

Authors:  José M. Miró; Asuncion Moreno; Carlos A. Mestres
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.